Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 16, 2011, Pages 6615-6620

  Hassaninasab, Azam ^a   Hashimoto, Yoshiteru ^a   Tomita Yokotani, Kaori ^a   Kobayashi, Michihiko ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Bioconversion; Microbial screening

Indexed keywords

BACTERIAL ENZYME; CURCUMIN; DIHYDROCURCUMIN; NADPH DEPENDENT CURCUMIN REDUCTASE; OXIDOREDUCTASE; PROTEIN SUBUNIT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TETRAHYDROCURCUMIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL METABOLISM; BACTERIUM IDENTIFICATION; BIOTRANSFORMATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENZYME PURIFICATION; ENZYME STABILITY; ENZYME SUBSTRATE; ESCHERICHIA COLI; FECES; GEL FILTRATION CHROMATOGRAPHY; GENE IDENTIFICATION; HUMAN; INTESTINE; ISOLATION PROCEDURE; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

BASE SEQUENCE; CURCUMIN; ESCHERICHIA COLI; HUMANS; INTESTINES; MOLECULAR SEQUENCE DATA; NADP; OXIDOREDUCTASES;

CURA; CURCUMA LONGA; ESCHERICHIA COLI;

EID: 79955598016     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1016217108     Document Type: Article

References (36)

1. Aggarwal BB, Sundaram C, Malani N, Ichikawa H (2007) Curcumin: The Indian solid gold. Adv Exp Med Biol 595:1-75.
2. Sharma RA, Gescher AJ, Steward WP (2005) Curcumin: The story so far. Eur J Cancer 41:1955-1968. (Pubitemid 41557681)
3. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV (2008) Curcumin: From ancient medicine to current clinical trials. Cell Mol Life Sci 65:1631-1652.
4. Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ (2007) Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102:1095-1104. (Pubitemid 47174225)
5. Nandakumar DN, Nagaraj VA, Vathsala PG, Rangarajan P, Padmanaban G (2006) Curcumin-artemisinin combination therapy for malaria. Antimicrob Agents Chemother 50:1859-1860.
6. Panchatcharam M, Miriyala S, Gayathri VS, Suguna L (2006) Curcumin improves wound healing by modulating collagen and decreasing reactive oxygen species. Mol Cell Biochem 290:87-96. (Pubitemid 44473238)
7. Ravindranath V, Chandrasekhara N (1981) In vitro studies on the intestinal absorption of curcumin in rats. Toxicology 20:251-257.
8. Crossman LC, et al. (2010) A commensal gone bad: Complete genome sequence of the prototypical enterotoxigenic Escherichia coli strain H10407. J Bacteriol 192: 5822-5831.
9. Zhou Z, et al. (2010) Derivation of Escherichia coli O157:H7 from its O55:H7 precursor. PLoS ONE 5:e8700.
10. Ferenci T, et al. (2009) Genomic sequencing reveals regulatory mutations and recombinational events in the widely used MC4100 lineage of Escherichia coli K-12. J Bacteriol 191:4025-4029.
11. Macconkey A (1905) Lactose-fermenting bacteria in feces. J Hyg (Lond) 5:333-379.
12. Levin M (1918) Differentiation of E. coli and A. aerogenes on a simplified eosin-methylene blue agar. J Infect Dis 23:43-47.
13. Durfee T, et al. (2008) The complete genome sequence of Escherichia coli DH10B: Insights into the biology of a laboratory workhorse. J Bacteriol 190:2597-2606. (Pubitemid 351466356)
14. Youn B, et al. (2006) Mechanistic and structural studies of apoform, binary, and ternary complexes of the Arabidopsis alkenal double bond reductase At5g16970. J Biol Chem 281:40076-40088. (Pubitemid 46041813)
15. Hori T, et al. (2004) Structural basis of leukotriene B4 12-hydroxydehydrogenase/15-Oxo-prostaglandin 13-reductase catalytic mechanism and a possible Src homology 3 domain binding loop. J Biol Chem 279:22615-22623. (Pubitemid 38679462)
16. Britton HTS, Robinson RA (1931) Universal buffer solutions and the dissociation constant of veronal. J Chem Soc 458:1456-1462.
17. Hoehle SI, Pfeiffer E, Sólyom AM, Metzler M (2006) Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver. J Agric Food Chem 54:756-764. (Pubitemid 43274111)
18. Pan MH, Huang TM, Lin JK (1999) Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27:486-494.
19. Ireson C, et al. (2001) Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 61: 1058-1064. (Pubitemid 32174425)
20. Ireson CR, et al. (2002) Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 11:105-111. (Pubitemid 34118319)
21. Persson B, Hedlund J, Jörnvall H (2008) Medium- and short-chain dehydrogenase/ reductase gene and protein families: The MDR superfamily. Cell Mol Life Sci 65: 3879-3894.
22. Nordling E, Jörnvall H, Persson B (2002) Medium-chain dehydrogenases/reductases (MDR). Family characterizations including genome comparisons and active site modeling. Eur J Biochem 269:4267-4276. (Pubitemid 35033496)
23. Vitale A, Rosso F, Barbarisi A, Labella T, D'Auria S (2010) Properties and evolution of an alcohol dehydrogenase from the Crenarchaeota Pyrobaculum aerophilum. Gene 461:26-31.
24. Pereira PJB, et al. (2001) Structure of human biliverdin IXbeta reductase, an early fetal bilirubin IXbeta producing enzyme. Nat Struct Biol 8:215-220. (Pubitemid 32180045)
25. Jörnvall H, Höög JO, Persson B (1999) SDR and MDR: Completed genome sequences show these protein families to be large, of old origin, and of complex nature. FEBS Lett 445:261-264.
26. Dick RA, Kensler TW (2004) The catalytic and kinetic mechanisms of NADPH-dependent alkenal/one oxidoreductase. J Biol Chem 279:17269-17277. (Pubitemid 38560485)
27. Strickland EH (1968) Circular dichroism of horseradish peroxidase and its enzyme-substrate compounds. Biochim Biophys Acta 151:70-75.
28. Mukhopadhyay A, Basu N, Ghatak N, Gujral PK (1982) Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents Actions 12:508-515. (Pubitemid 13218984)
29. Pari L, Murugan P (2007) Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Ren Fail 29:881-889. (Pubitemid 350130069)
30. Sugiyama Y, Kawakishi S, Osawa T (1996) Involvement of the β-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem Pharmacol 52:519-525. (Pubitemid 26253384)
31. Osawa T, Sugiyama Y, Inayoshi M, Kawakishi S (1995) Antioxidative activity of tetrahydrocurcuminoids. Biosci Biotechnol Biochem 59:1609-1612.
32. Yodkeeree S, Garbisa S, Limtrakul P (2008) Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via downregulation of MMPs and uPA. Acta Pharmacol Sin 29: 853-860.
33. Somparn P, Phisalaphong C, Nakornchai S, Unchern S, Morales NP (2007) Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol Pharm Bull 30:74-78. (Pubitemid 46066323)
34. Begum AN, et al. (2008) Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther 326: 196-208. (Pubitemid 351872144)
35. Ganguli M, et al. (2000) Apolipoprotein E polymorphism and Alzheimer disease. Arch Neurol 57:824-830.
36. Muthane U, Yasha TC, Shankar SK (1998) Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India. Ann Neurol 43:283-287. (Pubitemid 28113589)